Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2018-02-26 | Michael J. Finney, Ph.D., has served as a member of private Vaxarts board of directors since 2007. For fiscal 2018, he serves on the Audit Committee. No specific compensation stated. |
| 2019-03-11 | Michael J. Finney, Ph.D. has served as a member of our board of directors since February 2018 and previously served as a member of private Vaxarts board of directors since 2007. Since October 2004, Dr. Finney has served as the Managing Director of Finney Capital, an investment firm. |
| 2020-04-24 | Michael J. Finney, Ph.D. has served as a member of our board of directors since February 2018 and previously served as a member of Private Vaxart’s board of directors since 2007. |
| 2021-04-30 | Michael J. Finney, Ph.D. has served as a member of our board of directors since February 2018 and previously served as a member of Private Vaxart’s board of directors since 2007. Since October 2004, Dr. Finney has served as the Managing Director of Finney Capital, an investment firm. Since 1986, Dr. Finney has served as a founder, director and/or investor in various life sciences companies. Currently, he sits on six private company boards. From 2009 to 2011, Dr. Finney served as Vaxart’s Chief Executive Officer. Dr. Finney received an A.B. in biochemical sciences from Harvard University and a Ph.D. in biology (genetics) from the Massachusetts Institute of Technology. We believe Dr. Finney is qualified to serve on the board of directors because of his extensive experience within the life sciences industry, including as a venture capitalist. |
| 2022-04-28 | Michael J. Finney, Ph.D. has served as a member of our board of directors since February 2018... The following table provides membership and meeting information for each of the committees of the board of directors as of April 11, 2022: Michael J. Finney, Ph.D. serves on Audit and Compensation Committees... The following table provides director compensation information for each of the non-employee directors of the board of directors who served between January 1, 2021 and December 31, 2021: Michael J. Finney, Ph.D. received total compensation of $152,404. |
| 2023-04-28 | Michael J. Finney, Ph.D. has served as a member of our board of directors since February 2018 and Chairperson of our board of directors since March 2023. He previously served as a member of Private Vaxart’s board of directors since 2007. Since October 2004, Dr. Finney has served as the Managing Director of Finney Capital, an investment firm. Since 1986, Dr. Finney has served as a founder, executive, director and/or investor in various life sciences companies. Currently, he sits on seven private company boards. From 2009 to 2011, Dr. Finney served as Vaxart’s Chief Executive Officer. Dr. Finney received an A.B. in biochemical sciences from Harvard University and a Ph.D. in biology (genetics) from the Massachusetts Institute of Technology. The following table provides director compensation information for each of the non-employee directors of the board of directors who served between January 1, 2022 and December 31, 2022: Michael J. Finney, Ph.D. Fees Earned or Paid in Cash: $50,516, Stock Awards: $28,836, Option Awards: $152,670, Total: $232,022. |
| 2024-04-29 | Michael J. Finney, Ph.D. has served as a member of our board of directors since February 2018 and Chair of our board of directors since March 2023. |
Data sourced from SEC filings. Last updated: 2025-07-01